期刊文献+

携带hIFN-γ的增殖型腺病毒治疗胃癌的体外实验研究

In vitro Potent Antitumor Activity of the Oncolytic Adenovirus Expressing hIFN-γ in Gastric Cancer
下载PDF
导出
摘要 目的:研究增殖型腺病毒CNHK300-hIFN-γ在胃癌细胞中的增殖、杀伤能力与表达hIFN-γ蛋白的能力。方法:病毒增殖实验比较CNHK300-hIFN-γ与CNHK300在胃癌细胞SGC-7901与成纤维细胞BJ中的增殖能力;ELISA法比较CNHK300-hIFN-γ和复制缺陷型腺病毒Ad-hIFN-γ在细胞中hIFN-γ蛋白的表达量;细胞活力MTT检测法与CPE实验观察CNHK300-hIFN-γ对胃癌细胞与正常细胞的杀伤效应。结果:增殖实验结果表明CNHK300-hIFN-γ能选择性地在端粒酶阳性的胃癌细胞中大量增殖;ELISA实验结果表明CNHK300-hIFN-γ在胃癌细胞中hIFN-γ的表达量可至117.26±15.92ng/ml;MTT与CPE实验表明CNHK300-hIFN-γ对胃癌细胞有显著的杀伤性,对正常细胞无明显杀伤。结论:增殖型腺病毒CNHK300-hIFN-γ感染胃癌细胞后增殖活跃并能大量表达目的基因hIFN-γ,对胃癌细胞有明显杀伤作用但对正常细胞无明显杀伤,为胃癌的病毒基因治疗进一步提供了理论依据。 Objective: To compare the expression of hIFN-γ, replicative activities and anfitumor activities of CNHK300 - hIFN-γ and Ad - hIFN-γ in normal and gastric cancer cells. Method: The replicative activities of viruses in cells were measured by viral replication assay; CPE assay was used to detect the antitumor effect of viruses; The expression level of hIFN-γ in cancer cells was detected by ELISA. Result: The infection of CNHK300- hIFN-γ led to an obvious expression of hIFN-γ in gastric cancer ceils. The vector system CNHK300- hIFN-γpossessed more replicated potential than Ad - hIFN -γ and could specifically kill most of SGC - 7901 cells at MOI value of 0.1, which was much better than that by the traditional adenoviral vector. Conclusion: CNHK300- hIFN-γ can selectively replicate and effectively express hIFN-γ in tumor cells, and specifically kill gastric cancer cells, suggesting a splendid future as a new anticancer agent.
出处 《生物技术》 CAS CSCD 2008年第5期26-28,共3页 Biotechnology
关键词 增殖型腺病毒 胃癌 基因治疗 hIFN-γ conditionally replicating adenovirus gastric cancer gene therapy hIFN-γ
  • 相关文献

参考文献1

二级参考文献16

  • 1谭晓华,Zhu Qing,刘畅,刘秀丽,邵晓婷,魏兵.人AFP腺病毒载体感染的树突状细胞诱导小鼠抗肝癌免疫[J].中华肿瘤杂志,2006,28(1):13-16. 被引量:12
  • 2Grimm C F, Ortmann D, Mohr L, et al. Mouse alphafetoprotein-specific DNA-based immunotherapy of hepatocellular carcinoma leads to tumor regression in mice [J]. Gastroenterology, 2000,119 (4) : 1104-1112.
  • 3Shafer-Weaver K, Sayers T, Strobl S, et al. The Granzyme B ELISPOT assay: an alternative to the ^51Cr-release assay for monitoring cell-mediated cytotoxicity [J]. J Transl Med, 2003, 1(1):14.
  • 4Okada N, liyama S, Okada Y, et al. Immunological properties and vaccine efficacy of murine dendritic cells simultaneously expressing melanoma-associated antigen and interleukin-12 [J]: Cancer Gene Ther, 2005,12( 1 ) :72-83.
  • 5Nakamura M, lwahashi M, Nakamori M, et al. Dendritic cells genetically engineered to simultaneously express endogenous tumor antigen and granulocyte macrophage colony-stimulating factor elicit potent therapeutic antitumor immunity [J]. Clin Cancer Res, 2002,8 (8) : 2742-2749.
  • 6Elzey B D, Siemens D R, Ratliff T L, et al. Immunization with type 5 adenovirus recombinant for a tumor antigen in combination with recombinant canarypox virus (ALVAC) cytokine gene delivery induces destruction of established prostate tumors [J]. Int J Cancer, 2001,94(6):842-849.
  • 7Shyu R Y, Su H L, Yu J C, et al. Direct growth suppressive activity of interferon-alpha and -gamma on human gastric cancer cells [J]. J Surg Oncol, 2000,75(2) : 122-130.
  • 8Yang I, Kremen T J, Giovannone A J, et al. Modulation of major histocompatibility complex class Ⅰ molecules and major histocompatibility complex-bound immunogenic peptides induced by interferon-alpha and interferon-gamma treatment of human glioblastoma muhiforme [J]. J Neurosurg, 2004, 100 (2):310-319.
  • 9Garcia-Lora A, Algarra l, Garrido F. MHC class Ⅰ antigens, immune surveillance, and tumor immune escape [J]. J Cell Physiol, 2003,195 (3) : 346-355.
  • 10Shin E C, Shin W C, Choi Y, et al. Effect of interferongamma on the susceptibility to Fas (CD95/APO-1)-mediated cell death in human hepatoma cells [J]. Cancer Immunol Immunother, 2001,50( 1 ) :23-30.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部